Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goss, K. H.
Right arrow Articles by Groden, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goss, K. H.
Right arrow Articles by Groden, J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
Journal of Clinical Oncology, Vol 18, Issue 9 (May), 2000: 1967-1979
© 2000 American Society for Clinical Oncology


Biology of Neoplasia

Biology of the Adenomatous Polyposis Coli Tumor Suppressor

By Kathleen Heppner Goss, Joanna Groden

From the Howard Hughes Medical Institute, Department of Molecular Genetics, Biochemistry, and Microbiology, University of Cincinnati College of Medicine, Cincinnati, OH.

Address reprint requests to Joanna Groden, PhD, Department of Molecular Genetics, College of Medicine, University of Cincinnati, 231 Bethesda Ave, Cincinnati, OH 45267; email joanna.groden{at}uc.edu

ABSTRACT

ABSTRACT: The adenomatous polyposis coli (APC) gene was first identified as the gene mutated in an inherited syndrome of colon cancer predisposition known as familial adenomatous polyposis coli (FAP). Mutation of APC is also found in 80% of all colorectal adenomas and carcinomas and is one of the earliest mutations in colon cancer progression. Similar to other tumor suppressor genes, both APC alleles are inactivated by mutation in colon tumors, resulting in the loss of full-length protein in tumor cells. The functional significance of altering APC is the dysregulation of several physiologic processes that govern colonic epithelial cell homeostasis, which include cell cycle progression, migration, differentiation, and apoptosis. Roles for APC in some of these processes are in large part attributable to its ability to regulate cytosolic levels of the signaling molecule beta-catenin and to affect the transcriptional profile in cells. This article summarizes numerous genetic, biochemical, and cell biologic studies on the mechanisms of APC-mediated tumor suppression. Mouse models of FAP, in which the APC gene has been genetically inactivated, have been particularly useful in testing therapeutic and chemopreventive strategies. These data have significant implications for colorectal cancer treatment approaches as well as for understanding other disease genes and cancers of other tissue types.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
R. Meza, J. Jeon, S. H. Moolgavkar, and E. G. Luebeck
Age-specific incidence of cancer: Phases, transitions, and biological implications
PNAS, October 21, 2008; 105(42): 16284 - 16289.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
E. J. Groen, A. Roos, F. L. Muntinghe, R. H. Enting, J. de Vries, J. H. Kleibeuker, M. J. H. Witjes, T. P. Links, and A. P. van Beek
Extra-Intestinal Manifestations of Familial Adenomatous Polyposis
Ann. Surg. Oncol., September 1, 2008; 15(9): 2439 - 2450.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
Z. Liu, S.-W. Choi, J. W. Crott, M. K. Keyes, H. Jang, D. E. Smith, M. Kim, P. W. Laird, R. Bronson, and J. B. Mason
Mild Depletion of Dietary Folate Combined with Other B Vitamins Alters Multiple Components of the Wnt Pathway in Mouse Colon
J. Nutr., December 1, 2007; 137(12): 2701 - 2708.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Signoroni, M. Frattini, T. Negri, E. Pastore, E. Tamborini, P. Casieri, M. Orsenigo, L. Da Riva, P. Radice, P. Sala, et al.
Cyclooxygenase-2 and Platelet-Derived Growth Factor Receptors as Potential Targets in Treating Aggressive Fibromatosis
Clin. Cancer Res., September 1, 2007; 13(17): 5034 - 5040.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. M. Sodir, X. Chen, R. Park, A. E. Nickel, P. S. Conti, R. Moats, J. R. Bading, D. Shibata, and P. W. Laird
Smad3 Deficiency Promotes Tumorigenesis in the Distal Colon of ApcMin/+ Mice.
Cancer Res., September 1, 2006; 66(17): 8430 - 8438.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S.-J. Myung, R. M. Rerko, M. Yan, P. Platzer, K. Guda, A. Dotson, E. Lawrence, A. J. Dannenberg, A. K. Lovgren, G. Luo, et al.
15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis
PNAS, August 8, 2006; 103(32): 12098 - 12102.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. I. Fenton and N. G. Hord
Stage matters: choosing relevant model systems to address hypotheses in diet and cancer chemoprevention research
Carcinogenesis, May 1, 2006; 27(5): 893 - 902.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
M. B. Genter
Molecular Biology of the Nasal Airways: How Do We Assess Cellular and Molecular Responses in the Nose?
Toxicol Pathol, April 1, 2006; 34(3): 274 - 280.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
R. J. Canter, S. B. Kesmodel, D. F. Heitjan, N. K. Veeramachaneni, N. A. Mokadam, J. A. Drebin, and D. L. Fraker
Suppression of {beta}-Catenin by Antisense Oligomers Augments Tumor Response to Isolated Limb Perfusion in a Rodent Model of Adenomatous Polyposis Coli-Mutant Colon Cancer
Ann. Surg. Oncol., September 1, 2005; 12(9): 733 - 742.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
K. Steigerwald, G. K. Behbehani, K. A. Combs, M. C. Barton, and J. Groden
The APC Tumor Suppressor Promotes Transcription-Independent Apoptosis In vitro
Mol. Cancer Res., February 1, 2005; 3(2): 78 - 89.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. E. Moran, D. H. Hunt, S. H. Javid, M. Redston, A. M. Carothers, and M. M. Bertagnolli
Apc Deficiency Is Associated with Increased Egfr Activity in the Intestinal Enterocytes and Adenomas of C57BL/6J-Min/+ Mice
J. Biol. Chem., October 8, 2004; 279(41): 43261 - 43272.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
M. M. Huycke and H. R. Gaskins
Commensal Bacteria, Redox Stress, and Colorectal Cancer: Mechanisms and Models
Experimental Biology and Medicine, July 1, 2004; 229(7): 586 - 597.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Z. Xiao, B. T. Luke, G. Izmirlian, A. Umar, P. M. Lynch, R. K. S. Phillips, S. Patterson, T. P. Conrads, T. D. Veenstra, P. Greenwald, et al.
Serum Proteomic Profiles Suggest Celecoxib-Modulated Targets and Response Predictors
Cancer Res., April 15, 2004; 64(8): 2904 - 2909.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. C. C. Wong, E. S. F. Lo, K. C. Lee, J. K. C. Chan, and W. L. W. Hsiao
Prognostic and Diagnostic Significance of {beta}-Catenin Nuclear Immunostaining in Colorectal Cancer
Clin. Cancer Res., February 15, 2004; 10(4): 1401 - 1408.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. H. Diks, J. C. Hardwick, R. M. Diab, M. M. van Santen, H. H. Versteeg, S. J. H. van Deventer, D. J. Richel, and M. P. Peppelenbosch
Activation of the Canonical {beta}-Catenin Pathway by Histamine
J. Biol. Chem., December 26, 2003; 278(52): 52491 - 52496.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. Tarafa, E. Prat, R.-A. Risques, S. Gonzalez, J. Camps, M. Grau, E. Guino, V. Moreno, M. Esteller, J. G. Herman, et al.
Common Genetic Evolutionary Pathways in Familial Adenomatous Polyposis Tumors
Cancer Res., September 15, 2003; 63(18): 5731 - 5737.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Chen, I. Yang, R. Irby, K. H. Shain, H. G. Wang, J. Quackenbush, D. Coppola, J. Q. Cheng, and T. J. Yeatman
Regulation of Caspase Expression and Apoptosis by Adenomatous Polyposis Coli
Cancer Res., August 1, 2003; 63(15): 4368 - 4374.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
M. B. Genter, D. M. Burman, S. Vijayakumar, C. L. Ebert, and B. J. Aronow
Genomic analysis of alachlor-induced oncogenesis in rat olfactory mucosa
Physiol Genomics, December 26, 2002; 12(1): 35 - 45.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. A. Lamprecht and M. Lipkin
Migrating colonic crypt epithelial cells: primary targets for transformation
Carcinogenesis, November 1, 2002; 23(11): 1777 - 1780.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Koratkar, E. Pequignot, W. W. Hauck, and L. D. Siracusa
The CAST/Ei Strain Confers Significant Protection against ApcMin Intestinal Polyps, Independent of the Resistant Modifier of Min 1 (Mom1R) Locus
Cancer Res., October 1, 2002; 62(19): 5413 - 5417.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. B. Anderson, K. L. Neufeld, and R. L. White
Subcellular distribution of Wnt pathway proteins in normal and neoplastic colon
PNAS, June 25, 2002; 99(13): 8683 - 8688.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. Heppner Goss, C. Trzepacz, T. M. F. Tuohy, and J. Groden
Attenuated APC alleles produce functional protein from internal translation initiation
PNAS, June 11, 2002; 99(12): 8161 - 8166.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
I. Chau and D. Cunningham
Cyclooxygenase Inhibition in Cancer -- A Blind Alley or a New Therapeutic Reality?
N. Engl. J. Med., April 4, 2002; 346(14): 1085 - 1087.
[Full Text] [PDF]


Home page
Genome ResHome page
K. A. Silverman, R. Koratkar, L. D. Siracusa, and A. M. Buchberg
Identification of the Modifier of Min 2 (Mom2) Locus, a New Mutation That Influences Apc-Induced Intestinal Neoplasia
Genome Res., January 1, 2002; 12(1): 88 - 97.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Roh, D. W. Green, C. B. Boswell, J. A. Pippin, and J. A. Drebin
Suppression of {beta}-Catenin Inhibits the Neoplastic Growth of APC-Mutant Colon Cancer Cells
Cancer Res., September 1, 2001; 61(17): 6563 - 6568.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
R A Sharma, A J Gescher, K J O'Byrne, and W P Steward
Familiar drugs may prevent cancer
Postgrad. Med. J., August 1, 2001; 77(910): 492 - 497.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
N. S. Fearnhead, M. P. Britton, and W. F. Bodmer
The ABC of APC
Hum. Mol. Genet., April 1, 2001; 10(7): 721 - 733.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
K. STEIGERWALD, I. M SANTORO, J. J KORDICH, V. GISMONDI, C. TRZEPACZ, M. BADIALI, F GIANGASPERO, M G. BALKO, J. S GRAHAM, N. RATNER, et al.
A distinct splice form of APC is highly expressed in neurones but not commonly mutated in neuroepithelial tumours
J. Med. Genet., April 1, 2001; 38(4): 257 - 262.
[Full Text]


Home page
Genes Dev.Home page
M.-P. Gulli and M. Peter
Temporal and spatial regulation of Rho-type guanine-nucleotide exchange factors: the yeast perspective
Genes & Dev., February 15, 2001; 15(4): 365 - 379.
[Full Text]


Home page
J. Biol. Chem.Home page
A. S. Jaiswal and S. Narayan
p53-dependent Transcriptional Regulation of the APC Promoter in Colon Cancer Cells Treated with DNA Alkylating Agents
J. Biol. Chem., May 18, 2001; 276(21): 18193 - 18199.
[Abstract] [Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2000 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online